» Authors » Juan Francisco Pascual-Gazquez

Juan Francisco Pascual-Gazquez

Explore the profile of Juan Francisco Pascual-Gazquez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 13
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marmol-Perez A, Ubago-Guisado E, Llorente-Cantarero F, Cadenas-Sanchez C, Rodriguez-Solana A, Gil-Cosano J, et al.
Pediatr Res . 2024 Nov; PMID: 39516571
Objective: To investigate the associations of television (TV) watching time with bone parameters and to examine whether high lean mass attenuates the negative impact of watching TV more than one...
2.
Marmol-Perez A, Ubago-Guisado E, Gil-Cosano J, Llorente-Cantarero F, Pascual-Gazquez J, Munoz-Torres M, et al.
J Cachexia Sarcopenia Muscle . 2024 Aug; 15(5):2156-2163. PMID: 39164071
Background: Sarcopenia and low areal bone mineral density (aBMD) are prevalent musculoskeletal complications after paediatric cancer treatment. However, their relationship has not been examined in young paediatric cancers survivors. This...
3.
Marmol-Perez A, Gil-Cosano J, Ubago-Guisado E, Llorente-Cantarero F, Pascual-Gazquez J, Ness K, et al.
J Sport Health Sci . 2024 Jan; 13(3):419-427. PMID: 38219958
Background: Pediatric cancer survivors are at increased risk of muscle weakness and low areal bone mineral density (aBMD). However, the prevalence of muscle strength deficits is not well documented, and...
4.
Martinez-Sanchez M, Fuster J, Campillo J, Galera A, Bermudez-Cortes M, Llinares M, et al.
Cancers (Basel) . 2021 Jun; 13(10). PMID: 34064810
Acute leukemia is the most common malignancy in children. Most patients are cured, but refractory/relapsed AML and ALL are the first cause of death from malignancy in children. Maintenance chemotherapy...
5.
Olmos-Jimenez R, Diaz-Carrasco M, Galera-Minarro A, Pascual-Gazquez J, Espuny-Miro A
Int J Clin Pharm . 2016 Dec; 39(1):126-132. PMID: 27933487
Background The administration of triple intrathecal therapy with methotrexate, cytarabine and a corticosteroid for the prophylaxis and treatment of neoplastic cell infiltration in the central nervous system in hematological malignancies...